Skip to main content
Podcasts

Examining Positive Results of Treatment for Patients With Endometrial Cancer


June 29, 2020

php logoSarah Temkin, MD, board-certified gynecologic oncologist, and Don Dizon, MD, oncologist specializing in women’s cancers, discuss an ongoing Phase III trial that examines the use of selinexor for the treatment of endometrial cancer, and highlight what they hope to see for the future of care. 

Reference:

Vergote I, Hamilton EP, Romero I, et al. SIENDO/ENGOT-EN5: A randomized phase III trial of maintenance with selinexor/placebo after combination chemotherapy in patients with advanced or recurrent endometrial cancer. J Clin Oncol 38: 2020 (suppl; abstr TPS6105). doi: 10.1200/JCO.2020.38.15_suppl.TPS6105

Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top